Kestra Medical Technologies, Ltd. (KMTS)

Revenue by Product

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
Wearable Cardioverter Defibrillator	59.82M	Log In	Log In
Wearable Cardioverter Defibrillator Growth	115.05%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
United States	59.82M	Log In	Log In
United States Growth	115.05%	Log In	Log In